ACRS
USDAclaris Therapeutics Inc. Common Stock
$2.360-0.140 (-5.600%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.500
High
$2.599
Low
$2.315
Volume
3.54M
Company Fundamentals
Market Cap
255.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.05M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.05Current $2.360High $5.17
Related News
GlobeNewswire
Aclaris Therapeutics to Participate in Three November Healthcare Conferences
WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.